CISSS de Chaudière-Appalaches Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2019
NCT03843671
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

CISSS Chaudières-Appalaches (Hôtel-Dieu de Lévis) | CISSS de Chaudière-Appalaches

Active Ingredients

Drugs in Phase 2 Trials (1)

oxygen (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1